邢唷>? ???~??????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????  !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}????Root Entry???????? F喟Ga?SummaryInformation(????DocumentSummaryInformation8????????????\WordDocument????????1???? ?????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????蝙Oh?+'迟0?p?x?? ?5lenovo Normal.dotm~?I?@斤?O@???笙@?a<WPS Office_10.1.0.7401_F1E327BC-269C-435d-A152-05C5408002CA?胀?.??+,?D胀?.??+,??H?PX`h px5 ?(\?dlKSOProductBuildVer52052-10.1.0.74010Table????x Data ????????????R_WpsCustomData???????????? ????????????欹?? P6RKSKS1?%??????$$_$? a$h}:LsC 48*N?XY? N^4N?^%`??o??U_?^?o??T?;m'`bR ?ONT? ?c?FU ???!kyb?0W'k????!k yb??g??u?????uv????^??R:N4N?^%`??S?1Alectinib HydrochlorideChugai Pharmaceutical Co., Ltd.?,g2014/7/4?$vALK,RET??'`??$v?v??ALK ?3?'`^?\???Lv,^?\???Lv,{ N?ALK?v??b6RBR ??? g??uKQU?f<\?o???? gHe ?NKQU?f<\????vxvz>f:y,g??>fW?????U\uX[???25.7vs10.4 ? ? g?z?O?02PembrolizumabMerck Sharp & Dohme Corp.??2014/9/4?$vPD-1Zfg?r? }$v; l??'`?r? }$v; ^?\???Lv; 4Y??Lv; ?r? }$v????*Nyb??vPD-1?b6RBR ?(WY*N?$v-NGW>f:y?N?uHe ?$\vQ(W^?\???LvN0?N???uGW??[?N?guX[??3OlaparibAstraZeneca AB'k?2014/12/16?$vPARP-1,PARP-2,PARP-3ZfguS?Lv,?S?'`y???Lv,??uS?Lv, N?'`uS?Lv,BRCA?z??vZfguS?LvuS?Lv:N8^??Y??$v ?Zfg???S?u:N;N0Olaparib:NhQt??*N_??vPARP?b6RBR ?3gxvz>f:y???[paBR? ?Olaparib?f>f????U\uX[(19.1vs5.5).??N?z??v4N?^O? ??Yyb?(u?NY??v?OeaY?'`uS? N?Lv?v?c??u ??MR-N?\?o?iryb?(u?N?? ?X[(Wfnx4N?^?Bl04EvolocumabAmgen Europe B.V.'k?2015/7/15??@????PCSK9?????@???TP[?W??'`?????@??/fN?W? O'`?? ?^\U?? ?v^?Z?u}T0?g?????T??u/fsQ.?0Y??@l{|o?ir?T?O?b?^? g??u?TP[?W??'`?????@???HoFH ??v??^? ?FO/f ?1u?N?{|????@??4ls^yr+R? ?? g?vM???u?????,g??^????vM???Bl ?Ee?MR??N,g??^?\? gHe??uKb?0? g4N?^xvz>f:y ?evolocumab/f??uHoFH?vN? ?? ??:N?{|????O??Y?vM?LDL-C?v??uKb?0Evolocumab/f?MRhQt???Q/UN?yb??(u?NHoFH?vPCSK9?b6RBR05SiltuximabJanssen Biotech, Inc.??2014/4/23MQ???IL-6Y-N?aS?yr???U??(uo?6Elosulfase AlfaBiomarin Pharmaceutical Inc.??2014/2/14?QR??T?"??C6S,KSIVA?W?Y?.???MPS IVA/fU???0MPS IVA/fN?W? O?? ?1u?NSO?QM????Z???GAG ??v?v?SOv?N-YNp?JSsN??-6-kxx?o?v??GALNS ?:1Yb;m'`N? ? ?bGAG?vQ?"?irkxx??(? }?KS ??T6-kxx?o?? }(WYhV?[?T???Q?n.?? ?? ???hV?[?R???0g8^?yr?_:N?U\'`????No?0??A~Kb/g??;m???R0|T8T?R??P??T?g{k?0MPS?v??u;N?? g???ib ?@?r^???i ?0v??f???u0??MR-N?\?MPS IVA??uo?irbv??f?I{??u?? ?,g?/f/UNN??(u?NMPS IVA??????vo?ir ?^\4N?^%`?07SelexipagActelionPharmaceuticalsLtd??2015/12/21|T8T??IPreceptor?? ???S?? ???S/fN?%N?Z?u}T?v?? ?vQ-Nyr?'`?? ???S^\?NU??0 ?MR??Q?? N^?v(u?Nb?PAH?vyr_'`??uo?ir? g?8TeQ(u OmMRR }??0?ufWGr0?[?ufWGr?T?MRR<\\?\?0l?f?fWGr?T)ReY??Gr ?FO4N?^?X[(W*g????v?Bl0,g?? gxvz>f:y(u?N??u?? ???S?PAH ?WHO,{1? ??????U\?M?NO?PAH ?OOb??v?i?0:N4N?^??O?Y ??08BrodalumabKyowa Hakko Kirin Co., Ltd.?,g2016/7/4?????MQ???IL17RA?8^?W?Q\?,?Q\?sQ???p,????W?Q\?,???W?Q\?,?eWW??Q\??Q\?/fN?ba'`0Y?'`0MQ???Y???? ?M?NO??u;m??u ?%N??v??k0?????v{|+R:N???W ?h?fvQ T??m? ???????e ??Th????Q\b_b?XY ?0 O?o?ir?2u(lv?dT?MTX ?0???A0?b[ }?vQ?o?ir ?X[(WY?\o(W?'`0,g??Yxvz-N??fwQ g??uHe?gv^N??'`o?}Y ??MR??Q?f?dk\O(u:g6Ro?ir N^(u?N?Q\???u09Eculizumab'k??Alexion Europe SAS???? Alexion'k????2007/6/20@?????????\u?k??'k??C5????EpoR'k??5??'`aw w'`@???}v?\?,^?xQ?W?@??\??T?_; ???+?@?U??(uo?10CanakinumabNovartis Pharmaceuticals Corporation??2009/6/17MQ?????IL-1&beta??'`|^t^yr?'`sQ???p,?!TIU?sQ?vhTg'`?T?_ ??MQ?t?}vD?T?_,??'`0W-Nwm?,?$vOW{k?P[?SO?sQhTg'`?T?,sQ???p?!TIU?sQ?vhTg'`?T?_/fU?? ?:NW? O'`?p'`?? ?S???'`???W???p??T?_0Fz-??Nl?T?_0?u?QY???p??T?_I{0;N??h??:N??0??0sQ???0???I{0?????R?(W-N??MR? gHe??uo?ir ?4N?^%`?0?MR??Q:ON gHe??uo?ir11DenosumabAmgen Europe B.V.'k?2010/5/26?$vRANKL?l??'`?[SO$v, ?Lv, ?[SO$v, ????$v, Y?'`??$v, ???@??, {|?n'`sQ???p, ?(??u~g?????$v???sNO ?3/100N ?}Y??NR??t^ ??Kb/gRd?????%N??R????x?v????N?Rd??v-Nt??????nx? gHe?v??uKb? ?Denosumab?Yxvz>f:y?0R70%? N?v?$v??s12Fingolimod Hcl Ora LcapsulesNovartis Pharmaceuticals Corp??2010/9/21MQ?????S1PR1?S1PR3?S1PR5?S1PR4Y?'`lxS?U??(uo?13Teriflunomide0??2012/9/12^y???DHODH,MMP-9,MMP-2,MMP-3Y?'`lxS?U??(uo?14PonatinibAriad Pharmaceuticals Inc??2012/12/14?$vEPH receptor,FGFR,Src,VEGFR,Kit,FLT-3,PDGFR,VEGFR,TIE2,RETba'`???'`}v@??; %`'`????}v@??; }v@??Ponatinib :N,{ N?Bcr-Abl?v?v?T?b6RBR ??T315I?z??WBcr-Abl?v?wQ g?Heyr_'`?b6R\O(u ?? gHe??? g? Ol??f<\:N?h??vv?T?b6RBcr-Abl?v??vCML??uo?irnfM?X[(W?v0??v??z?_w??o?'`?v:w?015VedolizumabTakeda Pharmaceuticals U.S.A., Inc.??2014/5/20?mS??Integrin &alpha;4&beta;7?n?'`????p; KQWi`l?KQWi`?/fN??S?Nf?v??S??p?'`??0?????Nf ???8^ g?Y ?%`'`??????T??? ??g{k??s3%-10%??0?MR\?9h??u? ?;N??:N/ec?u??T????u ?;N??:NSASP05-ASA0? Nz??(?? }0kxU VdT0?b[ }I{0?n?'`????p/fN??S?Nf?vba'`????p ?? z+o??Y?\O ?Tv^???zT[ ??{k?s??20%-50% ??MR?v??uo?irS????u ?;N??:NSASP05-ASA0? Nz??(?? }0ACTH0????b6R?vv?? ?(WCD?TUC???p?? z?%c???\O(u ??dk???:N????u ?wQ g??}Y?v gHe'`?T?[hQ'` ?wQ gN?[4N?^O? ?:N4N?^??O ??016EliglustatGenzyme Corp??2014/8/19?QR??T?"??UGCGb"??U??(uo?,(u?N1?Wb"?l??? ?4N?^%`?0,g?:N,{?N??^irnd??u?SRT?? ?(u?N?^??vb"?l?I?W??017SecukinumabNovartis Pharma K.K.?,g2014/12/26?????MQ???IL-17A?Q\?,?Q\?sQ???p,:_?'` ???p?Q\?/fN?ba'`0Y?'`0MQ???Y???? ?M?NO??u;m(?? ?%N??v??k0 O?o?ir?2u(lv?dT?MTX ?0???A0?b[ }?vQ?o?ir ?X[(WY?\o(W?'`0,g??Yxvz-N??fwQ g??uHe?gv^N??'`o?}Y ??MR??Q?f?dk\O(u:g6Ro?ir N^(u?N?Q\???u018PalbociclibPfizerInc??2015/2/3?$vCDK4; CDK6sNz?LvhQt??*N N^?vCDK406?b6RBR ?(WhQt4N?^???-N>f:y??N?z??v4N?^??19IxekizumabELILILLYANDCOMPANY??2016/3/22????MQ???IL-17A?eWW??Q\?; ?Q\?sQ???p; ????W?Q\?; ???W?Q\?; ?8^?W?Q\??Q\?/fN?ba'`0Y?'`0MQ???Y???? ??Q\?/fN?ba'`0Y?'`0MQ???Y????0-N????Q\??M?NOM?NOu;m(??u???k ? O?o?ir?2u(lv?dT?MTX ?0???A0?b[ }?vQ?o?ir ?X[(WY?\o(W?'`0,g??Yxvz-N??fwQ g??uHe?gv^N??'`o?}Y ?,g?:NIL-17US?bo?ir ??IL-17AwQ g????v??T?R?Tyr_'`0?MR??Q?f?dk\O(u:g6Ro?ir N^(u?N?Q\???u020Enasidenib mesylateCELGENECORP??2017/8/1?$vIDH2%`'`??'`}v@??Enasidenib /fhQt??*Nyb??v???IDH2?z??vb? AML ???vo?ir ?IDH2?z?(WAML-N'Y?`S17%0??NY????vAML?MR\?h??v gHe??u ??Yxvz>f:y,g?(WwQ gIDH2?z??vY????vAML-N??_23%?v?[hQ??s?T8.2*Ng?v?c???021IcatibantShire Orphan Therapies GmbH'k?2008/7/11??@????BDKRB2W? O'`@??'`4l?W? O'`@??4l?/fN?U?0%N??v8^?r?SO>f'`W? O? ???????s:N1/500000(W4N?^ N ?HAE??O???/}?Y*N?VRf[?MO?S????S?0b????0?&^?T?U4Y0??0??\u?k:S??T/b???T?? ??vo???4l?Y?'`%`'`?\O0?U??\O???zo`KN?i? ?qS?u}T0?MR\? gHe??uKb?022DalfampridineAcorda Therapeutics Inc??2010/1/22MQ?????Potassium channelY?'`lxS?U??(uo?23VismodegibGenentech Inc??2012/1/30?$vSMO??^??Lv??^??Lv:Ng8^??v??v`'`?$v0Vismodegib:NhQt??*N N^hedgehog???b6RBR ???*N?yb?(u?N??u??^??Lv?vo?ir0?Yxvz>f:y(W? gHe??u?vl??'`??^??Lv??-N??0R43%?v?$v??s24ApremilastCelgene Corp??2014/3/21MQ???????PDE4?Q\?sQ???p; ?Q\??Q\?/fN?ba'`0Y?'`0MQ???Y????0-N????Q\??M?NOM?NOu;m(??u???k ? O?o?ir?2u(lv?dT?MTX ?0???A0?b[ }?vQ?o?ir ? gHe'` gP?NX[(WY?\o(W?'`0,g??Yxvz-N??fwQ g??uHe?gv^N??'`o?}Y0,g?:N?g??_?o? ?hQ??v\O(uv??0?MR??Q?f?dk\O(u:g6Ro?ir N^(u?N?Q\???u025RilonaceptRegeneron??2008/2/27MQ?????IL-1&alpha;,IL-1&beta?!TIU?sQ?vhTg'`?T?_,Fz-??Nl?T?_,??'`???W???p??T?_,??'`sN???|@???!TIU?sQ?vhTg'`?T?_/fU?? ?:NW? O'`?p'`?? ?S???'`???W???p??T?_0Fz-??Nl?T?_0?u?QY???p??T?_I{0;N??h??:N??0??0sQ???0???I{0?????R?(W-N??MR? gHe??uo?ir ?4N?^%`?026TetrabenazinePrestwick??2008/8/15?^y???x?^y?????VMAT2???l?H??????H??/fN?U??v8^?r?SO>f'`W? O? ??MR? gHe??uKb?0,g?:Nl?N??? ?? g4N?^xvz>f:y ?,g?(u?N??u????H??wQ gfnx?v?uHe027EcallantideDyax Corp.??2009/12/1@??????KLKB1W? O'`@??'`4l?W? O'`@??4l?/fN?U?0%N??v8^?r?SO>f'`W? O? ???????s:N1/500000(W4N?^ N ?HAE??O???/}?Y*N?VRf[?MO?S????S?0b????0?&^?T?U4Y0??0??\u?k:S??T/b???T?? ??vo???4l?Y?'`%`'`?\O0?U??\O???zo`KN?i? ?qS?u}T0?MR\? gHe??uKb?028Velaglucerase AlfaShire Human Genetic Therapies Inc??2010/2/26?QR??T?"???Glucosylceramidase replacementsb"??b"??(Gaucher disease)/f^\U?? ?:N?v?SO.??? ?:N8^?r?SO??'`W? O?0b"??;N??R:N^?^y????W(I?W)?^y????W(a!?W?b!?W)0??1u?Na??????v????z???:gSOa??????v?;m'`:ON ? ?bvQ?^ira??????(W??0>?0??0? ?u???v?lV???v?SO-N.?? ?b_bxQ?W?v.????sS b"??? ????/}??hV?[???? ?4N?^h??Y?hV?/}v^?L?'`?R?0?MR??u g$N??v??f??u? (ERT) ??^irnd??u? (SRT)0 Os|?v?/f?MR??Q/UN???_?vb"??yr_'`??uo?ir ?:NI?Wb"????uo?ir0,g?^\v??f??u? ?(u?NI?Wb"?? ?4N?^%`?029TafamidisPfizer Ltd'k?2011/11/16^y???TTRl?2u?z? }?}v??'`??|7hY?'`^y??,2u?z? }?}??}v??|7h?'`l?2u?z? }?}v??'`??|7hY?'`^y??:NN?U?? ?1u?N???z? ???8^?r?SO>f'`W? O?v??|7h?'`??0?MR? gHe??uKb?0FDA?TEMA?vQ??^y?_c?O?N?[paBR ?yb?vQ N^030Taliglucerase AlfaPfizer Inc??2012/5/10?QR??T?"??Glucosylceramideb"??b"??(Gaucher disease)/f^\U?? ?:N?v?SO.??? ?:N8^?r?SO??'`W? O?0?MR??u g$N??v??f??u? (ERT) ??^irnd??u? (SRT)0,g?(u?NI?Wb"???gv??f???uo?ir ?4N?^%`?031LomitapideAegerion Pharmaceuticals Inc??2012/12/21??@????MTP?TP[??'`?????@??; ?????@???TP[?W??'`?????@??/fN?W? O'`?? ?^\U?? ?v^?Z?u}T0?g?????T??u/fsQ.?0Y??@l{|o?ir?T?O?b?^? g??u?TP[?W??'`?????@???HoFH ??v??^? ?FO/f ?1u?N?{|????@??4ls^yr+R? ?? g?vM???u?????,g??^????vM???Bl ?Ee?MR??N,g??^?\? gHe??uKb?0? g4N?^xvz>f:y ?,g?(u?N??u,g??^? gHe'`fnx032Mipomersen SodiumGenzyme Corp??2013/1/29??@????APOB?TP[??'`?????@???TP[?W??'`?????@??/fN?W? O'`?? ?^\U?? ?v^?Z?u}T0?g?????T??u/fsQ.?0Y??@l{|o?ir?T?O?b?^? g??u?TP[?W??'`?????@???HoFH ??v??^? ?FO/f ?1u?N?{|????@??4ls^yr+R? ?? g?vM???u?????,g??^????vM???Bl ?Ee?MR??N,g??^?\? gHe??uKb?0? g4N?^xvz>f:y ?,g?(u?N??u,g??^? gHe'`fnx033DinutuximabUnitedTherapeuticsCorporation??2015/3/10?$vGD2^y????$v^y????$v???sNO ?Y??N?Q?0Dinutuximab/fFDA??*Nyb??v?????i?'`?v^y????$v?v??uo?ir034SonidegibNovartisPharmaceuticalsCorp??2015/7/24?$vSMO??^??Lv??^??Lv:Ng8^??v??Lv0Sonidegib:Nhedgehog???b6RBR ?wQ g??v\O(u:g6R ?(W?Yxvz-N>f:y??N??_??uTY??v??wQ g????uHe?ORR ?58% ?35Olaratumabf:y(W? gS?u?@x NT?TOlaratumab?>fW???uX[?26.5vs14.7g)36NusinersenBIOGENIDECINC??2016/12/23????????SMN2 ??'`???)U??(uo?37DeutetrabenazineTEVABRANDEDPHARM??2017/4/3????????VMAT2??'`?????x; ???l?H??????H??/fN?U??v8^?r?SO>f'`W? O? ??MR? gHe??uKb?0wQSO\O(u:g6RN? ?FO??:NN?[???vUS???\O(u gsQ0? g4N?^xvz>f:y ?,g?(u?N??u,g??^? gHe'`fnx038Dinutuximab BetaEUSA Pharma (UK) Limited'k?2017/5/8?$vGD2^y????$v^y????$v???sNO ?Y??N?Q???0Dinutuximab beta/f'k???*Nyb??v?????i?'`?v^y????$v?v??uo?ir0(WY????v^y????$v-N>f:y?N?uHe39Recombinant Human Nerve Growth Factor (Rhngf)Dompe farmaceutici s.p.a.'k?2017/7/6f ?NO?N? g??uo?ir046Ledipasvir And SofosbuvirGilead Sciences Inc??2014/10/10a?'`??NS5B,NS5AN??,g?:NhQ?g ???u??1b?WN??o?ir ??uHe??90%? N047Sofosbuvir; Velpatasvir; VoxilaprevirGILEADSCIENCESINC??2017/7/18a?'`??NS3/NS4A; NS5B; NS5AN??,g?(u?N?? g??uo?ir?He?vN????u ?:N?z4x'`??uo?ir048Elvitegravir, Cobicistat, Emtricitabine, And Tenofovir AlafenamideGileadSciencesInc??2015/11/5a?'`??CYP3A; pol; RT; HIV integrase~???,g?(u?N?? g~??????o??v??u ?wQ gf>f?v4N?^??uO?0 "&(:<DFP鲰铜??bB"?B*phCJOJPJQJo(^JaJ5KHmH sH nHtH_H?B*phCJOJPJQJo(^JaJ5KHmH sH nHtH_H?B*phCJOJPJQJo(^JaJ5KHmH sH nHtH_HCJ o(aJ 5H*\?B*phCJOJPJQJo(^JaJ5KHmH sH nHtH_H?B*phCJOJPJQJo(^JaJ5KHmH sH nHtH_H?B*phCJOJPJQJo(^JaJ5KHmH sH nHtH_HCJ o(aJ 5\CJ o(aJ 5\ PRVX^`jltv粼??iI)CJ o(aJ 5H*\?B*phCJOJPJQJo(^JaJ5KHmH sH nHtH_H?B*phCJOJPJQJo(^JaJ5KHmH sH nHtH_H?B*phCJOJPJQJo(^JaJ5KHmH sH nHtH_HCJ o(aJ 5H*\?B*phCJOJPJQJo(^JaJ5KHmH sH nHtH_H?B*phCJOJPJQJo(^JaJ5KHmH sH nHtH_H?B*phCJOJPJQJo(^JaJ5KHmH sH nHtH_HCJ o(aJ 5H*\ v~?????咴穿?~^S3?B*phCJOJPJQJo(^JaJ5KHmH sH nHtH_HCJ o(aJ 5H*\?B*phCJOJPJQJo(^JaJ5KHmH sH nHtH_HCJ o(aJ 5H*\?B*phCJOJPJQJo(^JaJ5KHmH sH nHtH_HCJ o(aJ 5H*\?B*phCJOJPJQJo(^JaJ5KHmH sH nHtH_HCJ o(aJ 5H*\?B*phCJOJPJQJo(^JaJ5KHmH sH nHtH_H   " 2 4 呃??laB7CJ o(aJ 5H*\?嗾东?kLA"DF??48嗔?xY:/CJ o(aJ 5H*\PRtvz|?呖??vkLA"+@+嗔?wW8-CJ o(aJ 5H*\8@8F8h8????嗾?xY:>>>(>嗔?xX8*>`>b>f>h>z>|>?>?>?>?>粽诗??vWL-"CJ o(aJ 5H*\?>?>????*?0?嗾?xY:?B?D?X?Z?嗔?wW8-CJ o(aJ 5H*\n(Ea$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfEa$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfFf?Ea$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$If>??s-Ea$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfEa$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfEa$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfFs-Ea$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfEa$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfEa$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfF68>Rn(Ea$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfEa$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfFftEa$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfRv|?s-Ea$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfEa$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfEa$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$If??s-Ea$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfEa$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfEa$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$Ifn(Ea$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfEa$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfFffEa$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfJPds-Ea$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfEa$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfEa$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$Ifdrs-Ea$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfEa$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfEa$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$Ifn(Ea$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfEa$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfFfXEa$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$Ifs-Ea$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfEa$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfEa$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$If8Fs-Ea$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfEa$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfEa$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfFRTZnn(Ea$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfEa$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfFfJEa$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$Ifns-Ea$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfEa$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfEa$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$If:ns-Ea$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfEa$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfEa$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfnXZ`xn(Ea$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfEa$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfFf<Ea$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$If?质 ?? ? Il?????????????????????????????????????????????????????? Ff?$$If:V?4l4l???????质 ?? ? Il?????????????????????????????????????????????????????? Ff?$$If:V?4l4l???????质 ?? ? Il?????????????????????????????????????????????????????? Fft$$If:V?4l4l???????质 ?? ? Il?????????????????????????????????????????????????????? Fff$$If:V?4l4l???????质 ?? ? Il?????????????????????????????????????????????????????? FfX$$If:V?4l4l???????质 ?? ? Il?????????????????????????????????????????????????????? FfJ$$If:V?4l4l???????质 ?? ? Il?????????????????????????????????????????????????????? Ff<$$If:V?4l4l???????质 ?? ? Il?????????????????????????????????????????????????????? Ff.$$If:V?4l4l???????质 ?? ? Il??????     8!"#$%&'()*+,-./01234567@9:;<=>?XABCDEFGHIJKLMNOPQRSTUVW`YZ[\]^_?abcdefghijklmnopqrstuvw?yz{|}~?xs-Ea$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfEa$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfEa$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$If ( s1Aa$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$?^??]?$IfEa$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfEa$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$If( 4 V"X"^"sn(Ea$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfFf.Ea$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfEa$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$If^"t"?"?"s-Ea$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfEa$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfEa$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$If?"???s-Ea$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfEa$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfEa$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$If??:#<#B#sn(Ea$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfFf Ea$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfEa$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfB#Z#?#?#s-Ea$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfEa$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfEa$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$If?#?#??s-Ea$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfEa$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfEa$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$If?????sn(Ea$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfFf!Ea$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfEa$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$If??%%s-Ea$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfEa$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfEa$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$If%(%.%D%s-Ea$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfEa$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfEa$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfD%L%?%?%?%sn(Ea$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfFf#Ea$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfEa$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$If?%???s-Ea$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfEa$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfEa$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$If??&&s-Ea$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfEa$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfEa$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$If&d&???sn(Ea$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfFf?Ea$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfEa$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$If?(($(s-Ea$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfEa$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfEa$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$If$(6(<(F(s-Ea$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfEa$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfEa$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfF(X(d)f)l)sn(Ea$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfFf?Ea$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfEa$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$Ifl)?)??s-Ea$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfEa$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfEa$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$If????s-Ea$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfEa$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfEa$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$If?*++$+sn(Ea$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfFf?Ea$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfEa$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$If$+@+p+v+s-Ea$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfEa$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfEa$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$Ifv+?+?+?s-Ea$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfEa$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfEa$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$If?????sn(Ea$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfFf?Ea$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfEa$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$If???????????????????????????????????????????????? Ff $$If:V?4l4l???????质 ?? ? Il?????????????????????????????????????????????????????? Ff!$$If:V?4l4l???????质 ?? ? Il?????????????????????????????????????????????????????? Ff#$$If:V?4l4l???????质 ?? ? Il?????????????????????????????????????????????????????? Ff?$$If:V?4l4l???????质 ?? ? Il?????????????????????????????????????????????????????? Ff?$$If:V?4l4l???????质 ?? ? Il?????????????????????????????????????????????????????? Ff?$$If:V?4l4l???????质 ?? ? Il?????????????????????????????????????????????????????? Ff?$$If:V?4l4l???????质 ?? ? Il?????????????????????????????????????????????????????? Ff?$$If:V?4l4l???????质 ?? ? Il?????????????????,,s-Ea$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfEa$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfEa$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$If,*,0,8,s-Ea$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfEa$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfEa$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$If8,D,---sn(Ea$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfFf?Ea$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfEa$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$If-0-J-P-s-Ea$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfEa$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfEa$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfP-d-v-?-s-Ea$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfEa$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfEa$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$If?-?-???sn(Ea$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfFf?Ea$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfEa$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$If???/s-Ea$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfEa$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfEa$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$If//$/P/s-Ea$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfEa$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfEa$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfP/??0?0?0sn(Ea$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfFf?Ea$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfEa$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$If?0???s-Ea$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfEa$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfEa$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$If????s-Ea$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfEa$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfEa$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$If? 1?1?1?sn(Ea$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfFf?2Ea$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfEa$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$If????s-Ea$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfEa$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfEa$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$If???2s-Ea$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfEa$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfEa$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$If222343:3sn(Ea$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfFf?4Ea$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfEa$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$If:3`3??s-Ea$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfEa$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfEa$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$If???4s-Ea$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfEa$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfEa$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$If44N6P6V6sn(Ea$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfFfx6Ea$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfEa$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfV6j6?6?6s-Ea$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfEa$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfEa$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$If?6?6??s-Ea$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfEa$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfEa$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$If?????sn(Ea$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfFfj8Ea$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfEa$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$If????s-Ea$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfEa$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfEa$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$If?8888s-Ea$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfEa$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfEa$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$If88@8999sn(Ea$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfFf\:Ea$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfEa$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$If??????????????????????????????????????? Ff?$$If:V?4l4l???????质 ?? ? Il?????????????????????????????????????????????????????? Ff?$$If:V?4l4l???????质 ?? ? Il?????????????????????????????????????????????????????? Ff?2$$If:V?4l4l???????质 ?? ? Il?????????????????????????????????????????????????????? Ff?4$$If:V?4l4l???????质 ?? ? Il?????????????????????????????????????????????????????? Ffx6$$If:V?4l4l???????质 ?? ? Il?????????????????????????????????????????????????????? Ffj8$$If:V?4l4l???????质 ?? ? Il?????????????????????????????????????????????????????? Ff\:$$If:V?4l4l???????质 ?? ? Il?????????????????????????????????????????????????????? FfN<$$If:V?4l4l???????质 ?? ? Il????????????????????????????????????????????9.9h9n9s-Ea$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfEa$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfEa$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$Ifn9?9?9?9s-Ea$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfEa$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfEa$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$If?9?; ;&;sn(Ea$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfFfN<Ea$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfEa$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$If&;J;d;j;s-Ea$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfEa$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfEa$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$Ifj;~;?;?;s-Ea$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfEa$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfEa$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$If?;? = ==sn(Ea$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfFf@>Ea$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfEa$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$If=*=f=l=s-Ea$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfEa$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfEa$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$Ifl=?=?=?=s-Ea$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfEa$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfEa$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$If?=?=>>>sn(Ea$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfFf2@Ea$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfEa$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$If>*>b>h>s-Ea$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfEa$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfEa$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$Ifh>|>?>?>s-Ea$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfEa$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfEa$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$If?>?>?D?sn(Ea$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfFf$BEa$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfEa$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfD?Z?`?f?s-Ea$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfEa$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfEa$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$Iff?|?????s-Ea$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfEa$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfEa$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$If????J@L@R@sn(Ea$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfFfDEa$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfEa$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfR@h@?@?@s-Ea$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfEa$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfEa$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$If?@?@??s-Ea$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfEa$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfEa$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$If?????sn(Ea$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfFfFEa$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfEa$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$If??A$As-Ea$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfEa$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfEa$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$If$A6ADAPAs-Ea$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfEa$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfEa$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfPArABB$Bsn(Ea$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfFf?Ea$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfEa$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$If$BFBxB~Bs-Ea$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfEa$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfEa$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$If~B?B?B?Bs-Ea$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfEa$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfEa$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$If?B?NCPCVCsn(Ea$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfFf?Ea$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfEa$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$If?????????? Ff@>$$If:V?4l4l???????质 ?? ? Il?????????????????????????????????????????????????????? Ff2@$$If:V?4l4l???????质 ?? ? Il?????????????????????????????????????????????????????? Ff$B$$If:V?4l4l???????质 ?? ? Il?????????????????????????????????????????????????????? FfD$$If:V?4l4l???????质 ?? ? Il?????????????????????????????????????????????????????? FfF$$If:V?4l4l???????质 ?? ? Il?????????????????????????????????????????????????????? Ff?$$If:V?4l4l???????质 ?? ? Il?????????????????????????????????????????????????????? Ff?$$If:V?4l4l???????质 ?? ? Il?????????????????????????????????????????????????????? Ff?$$If:V?4l4l???????质 ?? ? Il?????????????????????????????????????????????????????? Ff?$$If:V?4l4lVC???s-Ea$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfEa$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfEa$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$If??DDs-Ea$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfEa$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfEa$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfDD?E?E?Esn(Ea$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfFf?Ea$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfEa$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$If?E???s-Ea$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfEa$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfEa$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$If????s-Ea$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfEa$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfEa$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$If?HF???sn(Ea$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfFf?Ea$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfEa$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$If??H Hs-Ea$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfEa$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfEa$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$If H"H2H:Hs-Ea$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfEa$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfEa$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$If:HPH???sn(Ea$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfFf?Ea$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfEa$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$If?6I??s-Ea$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfEa$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfEa$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$If?? JJs-Ea$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfEa$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfEa$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfJ4JKKKsn(Ea$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfFf?Ea$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfEa$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfKVK LLs-Ea$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfEa$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfEa$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfL(L2L6Ls-Ea$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfEa$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfEa$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$If6L`LMMMsn(Ea$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfFf?Ea$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfEa$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfM?>0?Z??? @f@?A^AFB?BVCDE??6FDGHPH6IJ L?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~?????????????????????????????????Rv?4 ? < ? d ?  b?8jd?d.?>FR?dFnnx( ^"?"?B#?#??%D%?%?&?$(F(l)??$+v+??,8,-P-?-?/P/?0????2:3?4V6?6???889n9?9&;j;?;=l=?=>h>?>D?f???R@?@??$APA$B~B?BVC?D?E??? H:H??JKL6LMjM? NZN?N?XO?O?NP?P??Q?6R?     !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLM%G??z ??Times New Roman-???(?[SO;??????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????$PHPNPs-Ea$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfEa$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfEa$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfNPbPnP?Ps-Ea$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfEa$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfEa$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$If?P?P???sn(Ea$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfFfn[Ea$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfEa$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$If?fQ?Q?Qs-Ea$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfEa$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfEa$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$If?Q???s-Ea$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfEa$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfEa$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$If??2R4R6Rsnia$$Ff`]Ea$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$IfEa$$1$$$ $4$$dN?%dO?&dP?'dQ?[$\$VD?^?UD?]?$If/捌A ?.!?#?"?$?%?班2P1?80???????质 ?? ? Il?????????????????????????????????????????????????????? Ff?$$If:V?4l4l???????质 ?? ? Il?????????????????????????????????????????????????????? Ff?$$If:V?4l4l???????质 ?? ? Il?????????????????????????????????????????????????????? Ff?$$If:V?4l4l???????质 ?? ? Il?????????????????????????????????????????????????????? Ff?U$$If:V?4l4l???????质 ?? ? Il?????????????????????????????????????????????????????? Ff?W$$If:V?4l4l???????质 ?? ? Il?????????????????????????????????????????????????????? Ff|Y$$If:V?4l4l???????质 ?? ? Il?????????????????????????????????????????????????????? Ffn[$$If:V?4l4l???????质 ?? ? Il?????????????????????????????????????????????????????? Ff`]Wingdings7$???@? Calibri-?? ????N?[??lenovo~?I? ??h?g?j?!Z&!),.:;?]}    & 6"0000 0 000000??? ? ?????=?@?\?]?^??([{  0 0 00000??;?[???????P)?$P2?DDDD?Es%????? ???  ? 3 ???@